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Abstract
The basolateral amygdala (BLA) is involved in learning that certain environmental cues predict threatening events. Several
studies have shown that manipulation of neurotransmission within the BLA affects the expression of memory after fear
conditioning. We previously demonstrated that blockade of histaminergic H3 receptors decreased spontaneous release of
acetylcholine (ACh) from the BLA of freely moving rats, and impaired retention of fear memory. In the present study, we
examined the effect of activating H3 receptors within the BLA on both ACh release and expression of fear memory. Using the
microdialysis technique in freely moving rats, we found that the histaminergic H3 agonists R-a-methylhistamine (RAMH) and
immepip, directly administered into the BLA, augmented spontaneous release of ACh in a similar manner. Levels of ACh returned
to baseline on perfusion with control medium. Rats receiving intra-BLA, bilateral injections of the H3 agonists at doses similar to
those enhancing ACh spontaneous release, immediately after contextual fear conditioning, showed stronger memory for the
context±footshock association, as demonstrated by longer freezing assessed at retention testing performed 72 h later. Post-
training, bilateral injections of 15 ng oxotremorine also had a similar effect on memory retention, supporting the involvement of
the cholinergic system. Thus, our results further support a physiological role for synaptically released histamine, that in addition to
affecting cholinergic transmission in the amygdala, modulates consolidation of fear memories
Introduction
There is increasing evidence that neuronal histamine can affect
cognitive processes by modulating neuronal function throughout the
brain. Both physiological and morphological characteristics of
histaminergic neurons are coherent with such a role. Indeed,
histaminergic cells project profusely to the whole brain and spinal
cord (Watanabe et al., 1984; Panula et al., 1989), and ®re
spontaneously at variable rates (Reiner, 1987; Haas & Reiner,
1988) according to the circadian rhythm (Prast et al., 1988; Sakai
et al., 1990), or the behavioural state (Weiler et al., 1998). In
addition, recent evidence suggests that activation of histaminergic
receptors subtypes can regulate neuronal mitogen-activated protein
kinase (MAPK) phosphorylation (Blandina et al., 2001; Drutel et al.,
2001), and modulate plastic changes (Brown et al., 1995; Selbach
et al., 1997; Knoche et al., 1999; Ponomarenko et al., 2001), which
are two early cellular mechanisms likely involved in memory
consolidation (Schafe et al., 2001). Manipulation of the histaminergic
central system affects animal behaviour during several learning
paradigms (Meguro et al., 1995; Prast et al., 1996; Giovannini et al.,
1999); however, the results are often contradictory, as both
facilitatory and inhibitory effects of histamine on memory have
been described (Passani et al., 2000). Possible confounding factors
could be the systemic administration of histaminergic compounds, or
extensive lesions of the histaminergic tuberomammillary nuclei,
which are protocols that do not exclude effects on arousal, anxiety,
perception or other homeostatic mechanisms in which histamine is
involved (Sakai et al., 1990; Onodera et al., 1994; Philippu & Prast,
2001). As it is likely that the memory-modulating action of histamine
affects several brain regions differently, the procognitive or amnesic
effects of histamine can be evaluated with experimental protocols that
interfere with the exact timing of histamine release in discrete brain
regions, during the appropriate behavioural task. We recently
demonstrated that injections of histaminergic H3 receptor antagonists
in the basolateral complex of the amygdala (BLA) immediately post-
training, impaired memory consolidation of contextual fear condi-
tioning (Passani et al., 2001). The lateral and basal nuclei of the
amygdala are critical for learning information with highly emotional
components (see Maren, 2001; for a review), and several studies
showed that pharmacological manipulations affecting different hor-
mones and neurotransmitters, such as glucocorticoids (Roozendaal &
McGaugh, 1997), dopamine (Nader & LeDoux, 1999) and noradrena-
line (Liang et al., 1986), within the amygdala modulate memory for
aversive experiences (McGaugh & Izquierdo, 2000). One of the
mechanisms implicated seems to rest on the modulation of the
cholinergic function, as systemic or intra-BLA administration of
muscarinic cholinergic compounds affects memory retention and/or
the expression of fear responses in trained rats (Introini-Collison et al.,
1996; Rudy, 1996; Vazdarjanova & McGaugh, 1999). Interestingly,
when we perfused the BLA with H3 receptor antagonists at
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concentrations similar to those that affected fear memory, the
spontaneous release of ACh from the BLA of freely moving rats
signi®cantly decreased (Passani et al., 2001). According to our
hypothesis, then, blockade of H3 autoreceptors (Arrang et al., 1983b)
upregulates spontaneous histamine release, which in turn impairs
cholinergic neurotransmission and memory. The present experiments
further test our assumption by investigating the effect of H3 receptor
agonists on cholinergic function in the BLA of freely moving animals
and on contextual fear conditioning.
Materials and methods
Animal housing
Male Wistar rats (250±280 g) were housed in groups of three in a
temperature-controlled room (20±24 °C), on a 12 h light : 12 h dark
cycle and were allowed free access to food and water. All the
experiments were carried out in strict compliance with the EEC
recommendations for the care and use of laboratory animals (86/609/
CEE), and were approved by the Animal Care Committee of the
`Dipartimento di Farmacologia Preclinica e Clinica' of the
`UniversitaÂ di Firenze'.
Surgery and microdialysis
Cannulae (Metalant, Sweden) were implanted as described in Passani
et al. (2001). Brie¯y, rats were restrained in a stereotaxic frame
(Stellar, Stoelting Co., Wood Dale, IL, USA) under chloral hydrate
anaesthesia (400 mg/kg i.p.), and implanted with a guide cannula
according to the following coordinates (Paxinos & Watson, 1998):
AP = ±2.8, L = ±4.9, DV = 3.8 mm from bregma. The microdialysis
experiments were performed 24 h after surgery during which rats,
placed one per cage, recovered from surgery. On the day of the
experiments, the stylet was removed from the guide cannula and a
microdialysis probe (1.5 mm dialysing membrane molecular weight
cut-off = 6000 Da; Metalant, Sweden) was lowered into the BLA,
with the tip extending 4.5 mm beyond the tip of the guide cannula.
Ringer's solution (in mM: NaCl, 147; CaCl2, 1.2; KCl, 4.0; pH 7.0)
was perfused at the rate of 1.35 mL/min using a microperfusion pump
(CMA/100; Carnegie Medicine, Sweden).
Neostigmine bromide (0.1 mM), a cholinesterase inhibitor, was
added to the medium perfusing the BLA to recover detectable ACh
concentrations in the dialysate. Endogenous molecules, and exo-
genous compounds with molecular weight lower than 6000 Da, were
allowed to cross the dialysis membrane according to their concen-
tration gradient, and could be collected and administered, respect-
ively. After 2 h equilibration period, fractions were collected at
20 min intervals. The BLA was perfused with control medium in the
®rst three fractions to measure ACh spontaneous release and drugs
were then added to the medium.
Histology
The placement of microdialysis membranes was veri®ed post
mortem. Rats were killed with an overdose of chloral hydrate and
the brains were removed and stored in 10% formaline for 10 days.
Sections (40 mm) were then cut on a cryostate, mounted on gelatin-
coated slides and stained with cresyl violet for light microscopy. Data
from rats in which the membranes were not correctly positioned were
not included.
Assay of ACh
Acetylcholine was determined by HPLC-electrochemical detection as
described previously (Giorgetti et al., 2000). Brie¯y, ACh was
separated on a cation exchange column and hydrolysed by
acetylcholinesterase to form acetate and choline in the postcolumn
enzyme reactor. Choline was then oxidized by choline oxidase to
produce betaine and hydrogen peroxide, which was detected by a
platinum electrode with the potential set at 1.0 V. Peaks were
identi®ed by comparison of their retention times with those of the
standards.
Quanti®cation of ACh
The levels of ACh in the perfusates were calculated by comparison of
sample peak heights with external standard peak height, and
expressed as pmol/20 min. Calibration curves for ACh were
constructed by plotting the heights of peaks against the concentra-
tions. Regression lines were then calculated and determination of
unknown samples was carried out by the method of inverse
prediction. Spontaneous release of ACh was calculated for each
experiment by averaging the mean of the three 20 min samples of
perfusate collected before drug treatment. Release of ACh was
expressed as a percentage of its spontaneous release value. The
in vitro recovery of ACh from the dialysis membrane was about 60%
at room temperature. Values reported here were not corrected for
recovery.
Statistical analysis
All values are expressed as means 6 SEM, and the number of rats
used in each experiment is also indicated. The presence of signi®cant
treatment effects was ®rst determined by a one-way analysis of
variance (ANOVA) followed by Bonferroni's test. For all statistical
tests, P < 0.05 was considered signi®cant. For clarity purposes and
for biological relevance, we reported in ®gures and ®gure legends
only the signi®cant differences vs. the last sample before drug
treatment. Statistical analysis was performed using StatView (Abacus
Concepts, Inc., Berkeley, CA, USA) and GraphPad Prism (GraphPad
Software, Inc., San Diego, CA, USA).
Behavioural experiments
Experiments were performed on 7-day-old male albino Wistar rats
(average body weight 290 g). The animals were housed individually
in stainless steel cages in a room with a natural light±dark cycle
(windows) and constant temperature of 20 6 1 °C. The rats had free
access to food and water throughout the experiments.
Apparatus
A basic Skinner box module (Modular Operant Cage, Coulbourn
Instruments Inc. PA, USA) was used to induce contextual conditioned
freezing as in previous experiments (Sacchetti et al., 1999). The top
and the two opposite sides were aluminium panels and the other two
sides were transparent plastic. The ¯oor was made of stainless steel
rods connected to a shock delivery apparatus (Grid Floor Shocker,
model E13-08; Coulbourn Instruments Inc. PA, USA). The apparatus
was connected to a stimulus programming device (Scatola di
comando Arco 2340, Ugo Basile, Italy) to predetermine the number
and duration of the electric shocks and the duration of the intervals
between them. The apparatus was placed in an acoustically insulated
room kept at a constant temperature of 20 6 1 °C. Illumination
inside the room was 60 lux.
Contextual fear conditioning procedure
The rat was gently taken manually from the home cage to the
soundproof room. Once there, it was placed inside the conditioning
apparatus. The rat was left undisturbed for 3 min After this time,
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seven 1 s, 1 mA electric footshocks were administered at 30 s
intervals. Two minutes after the end of the stimulation, the rats were
removed, thus spending a total time of 8 min inside the conditioning
apparatus.
Conditioned freezing measurements
One of the behavioural manifestations of conditional fear in rats is
freezing, which consists of the complete absence of voluntary
movements. Freezing duration was measured 72 h after conditioning
by an experimenter unaware of the animal's treatment. To measure
freezing, the animals were again placed inside the conditioning
apparatus and left for 6 min, during which time they did not receive
electrical stimulation. After that, they were returned to the home
cage. The rat's behaviour was recorded by means of a closed circuit
television system. Freezing time was measured with a stop-watch. All
behavioural tests were performed between 10.00 h and 12.00 h.
Surgery and drug administration
Immediately after the training, rats were anaesthetized with ketamine
(100 mg/kg i.p), and bilateral injections performed in the following
10 min. Drugs dissolved in physiological saline were injected into the
BLA of rats restrained in a stereotaxic apparatus. The same
coordinates were used as for the implantation of the microdialysis
probes (according to Paxinos & Watson, 1998). The tip of the needle
was placed 8.7 mm ventral to bregma. The injection needle (outside
diameter, 0.3 mm) was connected with a short piece of polyethylene
tubing to a Hamilton syringe that was ®xed to an electrode holder.
Solutions (0.5 mL per side) were injected over a 1±2 min period and
the needle was left in place for another minute before withdrawing it.
Control groups received bilateral injections of saline.
Histology
At the end of the experiments, rats were deeply anaesthetized and the
brains were removed and stored in 10% formaline for 10 days.
Sections were cut with a freezing microtome and Nissl-stained to
verify injection sites.
Data analysis
For each session, data were expressed as seconds spent freezing
within the 6 min of testing. One-way ANOVA and Neuman±Keuls post
hoc tests were used. For all statistical tests, P < 0.05 was considered
signi®cant.
Chemicals
The substances used in this study included, neostigmine bromide
dihydrochloride, R-a-methylhistamine dihydrochloride (RBI, Natick,
MA, USA) and oxotremorine (Sigma Chemical Co. Ltd, UK).
Immepip dihydrobromide was kindly provided by Drs R. Leurs and
H. Timmerman (Vrije University, Amsterdam). All other reagents
and solvents were of HPLC grade or the highest grade available
(Sigma).
Results
Data analysis comprised only animals with correct placement of the
dialysing membranes within the boundaries of the BLA (< 90%).
Figure 1 shows the placement of the dialysing membranes in the
BLA of experimental rats that received perfusion of the H3 receptor
agonists.
H3 receptor agonists locally administered to the BLA increase
spontaneous ACh release
Microdialysis membranes were introduced in the cannulae 24 h after
surgery and perfused with Ringer's solution containing the cholin-
esterase inhibitor neostigmine (0.1 mM), which was necessary to
recover detectable concentrations of ACh. After a 120 min
equilibration period, the BLA spontaneously released ACh at stable
rates (0.12 6 0.01 pmol/20 min; n = 10, mean of all animals,
irrespective of group assignment) and did not change signi®cantly
with time. The effect of selective H3 receptor agonists were then
tested on the spontaneous release of ACh. When 1 mM of the potent
and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-yl-
FIG. 1. Schematic drawing illustrating the placement of microdialysis probes in the BLA (n = 10). The black bars represent the dialysing portion of the
probe. The position posterior to bregma were de®ned according to Paxinos & Watson (1998).
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methyl) piperidine (immepip; see Vollinga et al., 1994) was added to
the BLA perfusing medium for 40 min, ACh spontaneous release
increased by 72% 6 7% (Fig. 2). The maximum effect was achieved
during the second 20 min period of perfusion with immepip. Baseline
levels of ACh spontaneous release were quickly restored during
subsequent perfusion with control medium. Spontaneous, basal release
of ACh averaged 0.11 6 0.01 pmol/20 min (n = 5). A similar effect
was observed when the BLA was perfused for 40 min with another
selective H3 receptor agonist, R-a-methylhistamine (RAMH; Arrang
et al., 1987). When 10 mM RAMH was added to the BLA-perfusing
medium for 40 min, ACh spontaneous release increased signi®cantly,
with a maximal effect of 91% 6 11% (Fig. 3). The spontaneous, basal
release of ACh averaged 0.12 6 0.02 pmol/20 min (n = 5); levels
returned to baseline on wash out with normal saline.
Post-training infusions of H3 receptor and muscarinic receptor
agonists in the BLA affect expression of contextual fear
memory
The effect of RAMH and immepip on contextual fear conditioning
was examined in rats that had received post-training, bilateral
injections of these compounds in the BLA. Each drug was diluted in
saline to permit injection of a constant volume (0.5 mL per
amygdala). The position of the needle was examined post mortem,
and when either one or both needles were outside the BLA, the
animals were discarded (Fig. 4). The doses of RAMH and immepip
injected were chosen according to the results of the microdialysis
experiments. Therefore, 0.5 mL of a 10 mM solution of RAMH
corresponded to a total amount of 626 pg RAMH, and 0.5 mL of a
1 mM solution of immepip corresponded to 83 pg immepip. Rats that
received bilateral intra-BLA infusions of either RAMH or immepip
showed a stronger response for the footshock-context association, as
assessed by measuring the time spent freezing in the 72 h retention
test (Fig. 5). Analysis of variance on the freezing behaviour revealed
a signi®cant treatment effect (F6,76 = 6.147, P < 0.0001). Neuman±
Keuls post hoc analysis showed that rats receiving either 626 pg
RAMH (n = 10), or 82.6 pg immepip (n = 13) spent signi®cantly
more time freezing than saline-injected controls (n = 14; P < 0.01
and P < 0.05 vs. control). Similarly, rats that received intra-BLA
injections of the muscarinic agonist oxotremorine (15 ng; n = 14)
showed enhanced freezing (Fig. 5). There were no signi®cant
differences, however, between animals treated with 62.6 pg RAMH
(n = 12), 8.3 pg immepip (n = 10), 1.5 ng oxotremorine (n = 10) and
controls.
FIG. 3. Effect of 10 mM R-a-methylhistamine on ACh spontaneous release
from the BLA of freely moving rats. Spontaneous release was calculated for
each experiment by averaging the mean of the three samples collected
before the treatment. The bar indicates the period of drug application. Data
are means 6 SEM of ®ve experiments. Mean value of ACh spontaneous
release averaged 0.12 6 0.02 pmol/20 min *P < 0.05 vs. last sample before
drug treatment (ANOVA and Bonferroni's test).
FIG. 4. Photomicrograph of an operated brain, illustrating the placement of
injection needles in the BLA. Black arrows indicate the tip of the needles.
The schematic drawing illustrates the position of the coronal section
posterior to bregma according to Paxinos & Watson (1998).
FIG. 2. Effect of 1 mM immepip on ACh spontaneous release from the BLA
of freely moving rats. Acetylcholine levels were measured in fractions
collected every 20 min, beginning 2 h after the onset of the perfusion.
Spontaneous release was calculated for each experiment by averaging the
mean of the three samples collected before the treatment. Shown are
means 6 SEM of ®ve experiments. The mean of ACh spontaneous release
value averaged 0.11 6 0.01 pmol/20 min. The bar indicates the period of
immepip application. **P < 0.01 vs. last sample before drug treatment
(ANOVA and Bonferroni's test).
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Discussion
We have previously provided evidence that intra-BLA administration
of histaminergic H3 receptor antagonists impaired memory for
contextual fear conditioning and decreased spontaneous ACh release
(Passani et al., 2001). The ®ndings of this paper show that post-
training infusions of H3 receptor agonists in the BLA increase the
level of fear responses assessed at the retention test, and augment
spontaneous ACh release from the BLA. Therefore, cholinergic tone
within the amygdala can be modulated by histaminergic compounds
in a bimodal fashion, and the expression of fear memories can be
modi®ed accordingly. Moreover, our data further support previous
results demonstrating the requirement of muscarinic receptor activ-
ation in the BLA during consolidation of memory for aversive stimuli
(McGaugh, 2000). Both histaminergic ®bres from the tuberomam-
millary bodies (KoÈhler et al., 1985; Inagaki et al., 1990) and
cholinergic terminals from the nucleus basalis magnocellularis
(Mesulam et al., 1983) innervate the amygdala. According to
receptor binding (Pollard et al., 1993) and in situ hybridization
studies (Lovenberg et al., 1999), H3 receptors are abundant in the
BLA. Our results demonstrate a functional role for such receptors.
Indeed, the spontaneous release of ACh from the BLA was increased
by local perfusion with medium containing either 10 mM RAMH or
1 mM immepip, two selective and potent H3 receptor agonists with
pD2 values of 8.4 (Arrang et al., 1987) and 9.1 (Alves-Rodrigues
et al., 2001), respectively, in rat brain cortical slices.
We previously demonstrated that H3 receptor antagonists de-
creased spontaneous ACh release in the BLA, an effect fully
antagonized by the simultaneous perfusion with cimetidine, an H2
receptor antagonist (Passani et al., 2001). We proposed that the
blockade of H3 autoreceptors increased extracellular levels of
endogenous histamine, which impacted on H2 postsynaptic receptors;
consequently, the activation of H2 receptors decreased ACh release.
In addition to preventing the inhibition elicited by H3 antagonists,
administration of cimetidine alone increased ACh spontaneous
release, thus indicating the occurrence of a histaminergic, inhibitory
tone (Passani et al., 2001). Our present data lend further support to
this hypothesis, as local perfusion with selective H3 agonists, which
decrease spontaneous histamine release (Arrang et al., 1983a, b),
augmented ACh spontaneous output from the BLA. Moreover, this
study shows that local application of H3 receptor agonists in the BLA,
at concentrations similar to those that augment ACh release, improve
retention in a contextual fear test. Increased availability of ACh in the
synaptic cleft may account for this effect. Indeed, stimulation of
muscarinic receptors increased the levels of freezing, as shown by
post-training administration of oxotremorine. Although the injection
sites were centred in the BLA, some spill-over to adjacent
amygdaloid nuclei can not be excluded. However, the BLA receives
the densest cholinergic innervation of all amygdaloid nuclei (Ben-Ari
et al., 1977; Carlsen et al., 1985), therefore the observed effect was
probably mediated by a local circuit within the BLA. Furthermore,
the aversive effects on learning caused by lesions of cholinergic
afferents from the nucleus basalis magnocellularis (NBM) are
attenuated by infusions of cholinomimetic agents in the BLA
(Power & McGaugh, 2002). Our observations con®rm other reports
demonstrating the involvement of the amygdala cholinergic system in
Pavlovian fear-conditioning and aversive inhibitory avoidance
(Anagnostaras et al., 1999; Passani et al., 2001; Power et al.,
2002). They also suggest that the in¯uences of the histaminergic
system, similarly to those of other systems, such as the adrenergic,
glucocorticoid, opioid and GABAergic, (McGaugh et al., 1996) on
memories that involve the amygdala are ultimately mediated by the
activation of muscarinic, cholinergic receptors within the amygdala
itself. Post-training administration of these compounds excludes any
in¯uence of the treatment on acquisition and on other processes that
indirectly affect learning, thus con®rming our previous report that
histaminergic drugs modulate memory consolidation processes
(Passani et al., 2001). Histaminergic H3 receptor activation modulates
ACh release in other brain areas as well, apparently with modalities
that differ according to the cytoarchitectonics of different regions.
The cholinergic tone in the cortex is modulated by at least two
mechanisms, one at the level of the cholinergic cortical terminals
(Blandina et al., 1996), the other at the level of the cholinergic cell
bodies in the NBM (Cecchi et al., 2001). Local H3 receptor activation
by histamine and H3 receptor agonists inhibits ACh release from the
cholinergic terminals of the neocortex, through a neuronal arrange-
ment that involves GABAergic neurotransmission (Giorgetti et al.,
2000), and impairs performance in both passive avoidance and object
recognition tasks (Blandina et al., 1996). Conversely, in the NBM,
where the cholinergic somata are located, augmented levels of
histamine increased cortical ACh release via activation of H1
receptors (Cecchi et al., 2001). The speci®c behavioural signi®cance
of the interactions between the NBM cholinergic and histaminergic
systems, though, remains to be explored. In the hippocampus, ACh
spontaneous release is facilitated by either histamine or H3 receptor
antagonists when applied to the cholinergic septum in freely moving
animals, but not to the hippocampus itself (Bacciottini et al., 2002).
Interestingly, post-training blockade of H3 receptors in the septum
improved retention in a T-maze avoidance task, whereas H3 receptor
agonists had the opposite effect (Flood et al., 1998). The scenario
appears to be more complex in the ventral striatum, as ACh release
appears to be regulated indirectly by the activation of H3
autoreceptors and H3 heteroceptors located on dopaminergic and
GABAergic ®bres (Prast et al., 1999).
FIG. 5. Effects of post-training bilateral injection of H3 receptor agonists
and oxotremorine into the BLA on contextual fear conditioning.
Immediately after training, rats were injected with drugs under general
anaesthesia. Seventy-two hours after training, freezing was measured during
the 6 min period of testing. Each bar represents the mean value 6 SEM of
(n) rats. **P < 0.01 and *P < 0.05 vs. control (ANOVA and Neuman±Keuls's
test).
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The relevance of the neuronal histamine system in learning and
memory is beginning to be evaluated. Several studies support a
memory enhancing effect of histamine but there is also much
evidence that histamine impairs cognitive functions (Passani et al.,
2000). A partial explanation of these discrepancies could be the
distinct action that the histaminergic system exerts on cholinergic
neurotransmission in different brain structures (Bacciottini et al.,
2001). Our data are in agreement with the impairing effect of
histamine on the acquisition of an avoidance task, when administered
locally to the basolateral amygdala (Alvarez & Ruarte, 2002).
Similarly, histamine inhibits performance in an active avoidance task
when injected directly in the ventral hippocampus (Alvarez &
Banzan, 1995). In other brain regions, though, histamine exerts the
opposite effect, as locally applied H3 receptor agonists (that
presumably decrease histamine availability) have memory-impairing
effects on a T-maze avoidance task, as demonstrated in mice that
received intraseptum injections of imetit (Flood et al., 1998).
In recent studies, several intracellular processes have been
implicated in fear-induced memories, including protein synthesis,
and activation of the MAPK pathway (Atkins, 1998; Schafe &
LeDoux, 2000; Schafe et al., 2000; Weeber et al., 2000; Lin et al.,
2002). Activation of H3 receptors, as well, induces phosphorylation of
ERK1/2 in rat hippocampal slices (Blandina et al., 2001) and in
transfected COS-7 cells (Drutel et al., 2001). Therefore the memory
enhancing effect of H3 receptor agonists in the amygdala could rely
on sequential or parallel mechanisms that include modulation of
cholinergic neurotransmission and/or activation of the MAPK
pathway.
Clearly, much remains to be done to elucidate the role of the
histaminergic system in cognition. It is intriguing that the recently
developed H3 receptor-de®cient mice display normal memory
response in a passive avoidance task (Toyota et al., 2001).
However, memory is a complex process that consists of related but
dissociable events that involve distinct brain regions activated to
different degrees and at different times in the elaboration of disparate
learning situations. The amygdala constitutes one of the core
elements of a circuit that regulates emotional responses (Davidson
et al., 2000), and human neuroimaging studies have shown that the
amygdala is active in response to emotionally salient cues (Whalen
et al., 1998; Morris et al., 1999). Patients with bilateral damage of the
amygdala have altered perception of fearful stimuli (Adolphs et al.,
1994; Anderson & Phelps, 2001); in addition, an abnormal activation
of the amygdala in disorders such as social phobia (Birbaumer et al.,
1998) and in impulsive aggression has been postulated (Emery &
Amaral, 2000).
Several investigations have supported the idea of a central
histaminergic system implicated in arousal and in various homeo-
static mechanisms. Histaminergic ®bres innervate cholinergic
neurons in the basal forebrain and pontine nuclei that provide
cortical and thalamic inputs, respectively, and promote arousal.
Indeed, in vivo injections of histamine into the pedunculopontine
nuclei determines cortical desynchronization and promotes wakeful-
ness (Lin et al., 1996). By contrast, activation of histaminergic ®bres
in the lateral geniculate appears to strengthen central transmission of
afferent information, suggesting that sensory input enhancement
could be one way in which the histaminergic system plays a role in
arousal (Uhlrich et al., 2002). Recently it was demonstrated that the
arousal effect of orexin, the neuropeptide associated with regulation
of sleep and feeding, depends on the activation of histaminergic
neurotransmission (Huang et al., 2001). In addition, there appears to
be reciprocal contacts between histaminergic and orexin neurons,
suggesting that the two systems may cooperate in the regulation of
rapid eye movement sleep and feeding (Eriksson et al., 2001).
It has been proposed that brain histamine is a danger response
signal, triggered by a variety of aversive stimuli such as stress,
dehydration and hypoglycaemia (Brown et al., 2001). The present
results, together with our previous data (Passani et al., 2001), are
coherent with the hypothesis that the histaminergic system could
provide a crucial mechanism to ®ne tuning amygdala activation for an
adequate behavioural response.
Abbreviations
ACh, acetylcholine; BLA, basolateral amygdala; immepip, 4-(1H-imidazol-4-
yl-methyl) piperidine; MAPK, mitogen-activated protein kinase; NBM,
nucleus basalis magnocellularis; RAMH, R-a-methylhistamine.
References
Adolphs, R., Tranel, D., Damasio, H. & Damasio, A. (1994) Impaired
recognition of emotion in facial expressions following bilateral damage to
the human amygdala. Nature, 372, 669±672.
Alvarez, E.O. & Banzan, A.M. (1995) Effects of localized microinjections into
the hippocampal formation on the retrieval of a one-way active avoidance
response in rats. J. Neural TransmGen. Sect., 101, 201±211.
Alvarez, E. & Ruarte, M. (2002) Histaminergic neurons of the ventral
hippocampus and the baso-lateral amygdala of the rat: functional interaction
on memory and learning mechanisms. BehavBrain Res., 128, 81±90.
Alves-Rodrigues, A., Lemstra, S., Vollinga, R., Menge, W., Timmerman, H. &
Leurs, R. (2001) Pharmacological analysis of immepip amd imetit
homologous. Further evidence for histamine H3 receptor heterogeneity.
BehavBrain Res., 124, 121±127.
Anagnostaras, S., Maren, S., Goodrich, J.S. & Fanselow, M. (1999)
Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis.
Neuropsychopharmacology, 21, 731±744.
Anderson, A. & Phelps, E. (2001) Lesions of the human amygdala impair
enhanced perception of emotionally salient events. Nature, 411, 305±309.
Arrang, J., Drutel, G. & Schwartz, J. (1983a) Characterization of histamine H3
receptors regulating acetylcholine release in rat entorhinal cortex. Br. J.
Pharmacol., 114, 1518±1522.
Arrang, J.M., Garbarg, M. & Schwartz, J.C. (1983b) Auto-inhibition of brain
histamine release mediated by a novel class (H3) of histamine receptor.
Nature, 302, 832±837.
Arrang, J.M., Garbarg, M., Lancelot, J.C., Lecont, J.M., Pollard, H., Robba,
M., Schunack, W. & Schwartz, J.C. (1987) Highly-potent and selective
ligands for histamine-H3 receptors. Nature, 327, 117±123.
Atkins, C.M. (1998) The MAPK cascade is required for mammalian
associative learning. Nature Neurosci., 1, 602±609.
Bacciottini, L., Passani, M.B., Giovannelli, L., Cangioli, I., Mannaioni, P.F.,
Schunack, W. & Blandina, P. (2002) Endogenous histamine in the medial
septum-diagonal band complex increases the release of acetylcholine from
the hippocampus: a dual-probe microdialysis study in the freely moving rat.
Eur. J. Neurosci., 15, 1669±1680.
Bacciottini, L., Passani, M.B., Mannaioni, P.F. & Blandina, P. (2001)
Interactions between histaminergic and cholinergic systems in learning and
memory. Behav. Brain Res., 124, 183±194.
Ben-Ari, Y., Zigmond, R.E., Shute, C.C.D. & Lewis, P.R. (1977) Regional
distribution of cholinergic acetyltransferase and acetylcholinesterase within
the amygdala complex and stria terminalis. Brain Res., 120, 435±445.
Birbaumer, N., Grodd, W., Diedrich, O., Klose, U., Erb, M., Lotze, M.,
Scheider, F. & Weiss & Flor, H. (1998) fMRI reveals amygdala activation
to human faces in social phobia. Neuroreport, 9, 1223±1226.
Blandina, P., Giorgetti, M., Cecchi, M., Leurs, R., Timmerman, H. &
Giovannini, M.G. (1996) Histamine H3 receptor inhibition of K
+-evoked
release of acetylcholine from rat cortex in vivo. In¯amm. Res., 45, S54±S55.
Blandina, P., Mannaioni, P.F. & Giovannini, M.G. (2001) Histamine
Receptors activate MAPK signaling pathway in rat hippocampus: Soc.
Neurosci. Abstr., 27, 824.2.
Brown, R.E., Fedorov, N.B., Haas, H.L. & Reymann, K.G. (1995)
Histaminergic modulation of synaptic plasticity in area CA1 of rat
hippocampal slices. Neuropharmacology, 34, 181±190.
526 I. Cangioli et al.
ã 2002 Federation of European Neuroscience Societies, European Journal of Neuroscience, 16, 521±528
Brown, R.E., Stevens, D.R. & Haas, H.L. (2001) The physiology of brain
histamine. Prog. Neurobiol., 63, 637±672.
Carlsen, J., Zaborszky, L. & Heimer, L. (1985) Cholinergic projections from
the basal forebrain to the basolateral amygdala complex: a combined
retrograde ¯uorescent and immunohistochemical study. J. Comp. Neurol.,
234, 155±167.
Cecchi, M., Passani, M.B., Bacciottini, L., Mannaioni, P.F. & Blandina, P.
(2001) Cortical Acetylcholine release elicited by stimulation of histamine
H1 receptors in the nucleus basalis magnocellularis: a dual probe
microdialysis study in the freely moving rat. Eur. J. Neurosci., 13, 68±78.
Davidson, R., Putnam, K. & Larson, C. (2000) Dysfunction in the neural
cisrcuitry of emotion regulation-A possible prelude to violence. Science,
289, 591±594.
Drutel, G., Peitsaro, N., Karlstedt, K., Wieland, K., Smit, M., Timmerman, H.,
Panula, P. & Leurs, R. (2001) Identi®cation of rat H3 receptor isoforms with
different brain expression and signaling properties. Mol. Pharmacol., 59, 1±8.
Emery, N. & Amaral, D. (2000) In Lane, R.D. & Nadel, L. (Eds), The
Cognitive Neuroscience of Emotion. Oxford University, New York, NY.
Eriksson, K., Sergeeva, O., Brown, R. & Haas, H. (2001) Orexin/hypocretin
excites the histaminergic neurons of the tuberomammillary nucleus.
J. Neurosci., 21, 9273±9279.
Flood, J.F., Uezu, K. & Morley, J.E. (1998) Effect of histamine H2 and H3
receptor modulation in the septum on post-training memory processing.
Psychopharmacology, 140, 279±284.
Giorgetti, M., Bacciottini, L., Giovannini, M.G., Colivicchi, M.A., Goldfarb, J.
& Blandina, P. (2000) Local GABAergic inhibitory tone of acetylcholine
release from the cortex of freely moving rats. Eur. J. Neurosci., 12, 1941±
1948.
Giovannini, M.G., Bartolini, L., Bacciottini, L., Greco, L. & Blandina, P.
(1999) Effects of histamine H3 receptor agonists and antagonists on
cognitive performance and scopolamine-induced amnesia. Behav. Brain
Res., 104, 147±155.
Haas, H.L. & Reiner, P.B. (1988) Membrane properties of histaminergic
tuberomammilary neurones of the rat hypothalamus in vitro. J. Physiol.
(Lond.), 399, 633±646.
Huang, Z.-L., Qu, W.-M., Li, W.-D., Mochizuki, T., Eguchi, N., Watanabe, T.,
Urade, Y. & Hayaishi, O. (2001) Arousal effect of orexin A depends on
activation of the histaminergic system. Proc. Natl. Acad. Sci. USA, 98,
9965±9970.
Inagaki, N., Toda, K., Taniuchi, I., Panula, P., Yamatodani, A., Tohyama, M.,
Watanabe, T. & Wada, H. (1990) An analysis of histaminergic efferents of
the tuberomammillary nucleus to the medial preoptic area and inferior
colliculus of the rat. Exp. Brain Res., 80, 374±380.
Introini-Collison, I.B., Dalmaz, C. & McGaugh, J.L. (1996) Amygdala beta
noradrenergic in¯uences on memory storage involve cholinergic activation.
Neurobiol. Learn. Mem., 65, 57±64.
Knoche, A., Yokoyama, H. & Haas, H. (1999) Histaminergic modulation of 200
Hz oscillations in the hippocampus in vivo. P¯ugers Arch., 437, P22±P23.
KoÈhler, C., Swanson, L.W., Haglund, L. & Wu, J.Y. (1985) The
cytoarchitecture, histochemistry, and projections of the tuberomammillary
nucleus in the rat. Neuroscience, 16, 85±110.
Liang, K., Juler, R. & McGaugh, J. (1986) Modulating effects of posttraining
epinephrine on memory: involvement of the amygdala noradrenergic
system. Brain Res., 368, 125±133.
Lin, J.S., Hou, Y., Sakai, K. & Jouvet, M. (1996) Histaminergic descending
inputs to the mesopontine tegmentum and their role in the control of cortical
activation and wakefulness in the cat. J. Neurosci., 16, 1523±1537.
Lin, C.-H., Yeh, S.-H., Lin, C.-H., Lu, K.-T. & Leu, Chang, T.-H., W.-
C.&.Gean1, P.-W. (2002) A Role for the PI-3 Kinase Signaling Pathway in
Fear Conditioning and Synaptic Plasticity in the Amygdala. Neuron, 31,
841±851.
Lovenberg, T.W., Roland, B.L., Wilson, S.J., Jiang, A., Pyati, J., Huvar, A.,
Jackson, M.R. & Erlander, M.G. (1999) Cloning and functional expression
of the human histamine H3 receptor. Mol. Pharmacol., 55, 1101±1107.
Maren, S. (2001) Neurobiology of Pavlovian fear conditioning. Annu. Rev.
Neurosci., 24, 897±931.
McGaugh, J.L. (2000) Memory: a century of consolidation. Science, 287, 248±
251.
McGaugh, J.L., Cahill, L. & Roozendaal, B. (1996) Involvement of the
amygdala in memory storage: Interaction with other brain systems. Proc.
Natl. Acad. Sci.USA, 93, 13508±13514.
McGaugh, J.L. & Izquierdo, I. (2000) The contribution of pharmacology to
research on the mechanisms of memory formation. Trends Pharmacol. Sci.,
21, 208±210.
Meguro, K.-I., Yanai, K., Sakai, N., Sakurai, E., Maeyama, K., Sasaki, H. &
Watanabe, T. (1995) Effects of thioperamide, a histamine H3 antagonist, on
the step-through passive avoidance response and histidine decarboxylase
activity in senescence-accelerated mice. Pharmacol. Biochem. Behav., 50,
321±325.
Mesulam, M.M., Mufson, E.J., Wainer, B.H. & Levey, A.I. (1983) Central
cholinergic pathways in the rat: an overview based on an alternative
nomenclature (Ch1-Ch6). Neuroscience, 10, 1185±1201.
Morris, J., Ohman, A. & Dolan, R. (1999) A subcortical pathway to the right
amygdala mediating `unseen' fear. Proc. Natl Acad. Sci. USA, 96, 1680±
1685.
Nader, K. & LeDoux, J. (1999) Inhibition of the mesoamygdala dopaminergic
pathway impairs the retreival of conditioned fear associations. Behav.
Neurosci., 113, 891±901.
Onodera, K., Yamatodani, A., Watanabe, T. & Wada, H. (1994) Neuro-
pharmacology of the histaminergic neuron system in the brain and its
relationship with behavioral disorders. Progr. Neurobiol., 42, 685±702.
Panula, P., Pirvola, U., Auvinen, S. & Airaksinen, M.N. (1989)
Histamine-immunoreactive nerve ®bers in the rat brain. Neuroscience, 28,
585±610.
Passani, M.B., Bacciottini, L., Mannaioni, P.F. & Blandina, P. (2000) Central
histaminergic system and cognitive processes. Neurosci. Biobehav. Rev., 24,
107±114.
Passani, M.B., Cangioli, I., Baldi, E., Bucherelli, C., Mannaioni, P.F. &
Blandina, P. (2001) Histamine H3 receptor-mediated impairment of
contextual fear conditioning, and in-vivo inhibition of cholinergic
transmission in the rat basolateral amygdala. Eur. J. Neurosci., 14, 1522±
1532.
Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates.
Academic Press, New York.
Philippu, A. & Prast, H. (2001) Importance of histamine in modulatory
processes, locomotion and memory. Behav. Brain Res., 124, 151±159.
Pollard, H., Moreau, J., Arrang, J.M. & Schwartz, J.-C. (1993) A detailed
autoradiographic mapping of histamine H3 receptors in rat brain areas.
Neuroscience, 52, 169±189.
Ponomarenko, A., Knoche, A., Yokoyama, H., Vogel, Y., Brown, R. &
Haas, H. (2001) Histaminergic modulation of the hippocampal high-
frequency (200 Hz) oscillations in the rat. 30th European Histamine
Research Society Meeting, March 9±12, 2001, Turku Finland, pp. 64.
Power, A.E. & McGaugh, J.L. (2002) Phthalic acid amigdalopetal lesion of the
nucleus basalis magnocellularis indeces reversible memory de®cits in rats.
Neurobiol. Learn. Mem., 77, 372±388.
Power, A.E., Thal, L.J. & McGaugh, J.L. (2002) Lesions of the nucleus basalis
magnocellularis induced by 192 IgG-saporin block memory enhancement
with posttraining norepinephrine in the basolateral amygdala. Proc. Natl.
Acad. Sci. USA, 99, 2315±2319.
Prast, H., Argyriou, A. & Philippu, A. (1996) Histaminergic neurons facilitate
social memory in rats. Brain Res., 734, 316±318.
Prast, H., Saxer, A. & Philippu, A. (1988) Pattern of in vivo release of
endogenous histamine in the mammilary body and the amygdala. Naunyn-
Schmiedeberg's Arch. Pharmacol., 337, 53±57.
Prast, H., Tran, M., Fischer, H., Kraus, M., Lamberti, C., Grass, K. & Philippu,
A. (1999) Histaminergic neurons modulate acethylcholine release in the
ventral striatum: role for H3 histamine receptors. Naunyn-Schmiedeberg's
Arch. Pharmacol., 360, 558±564.
Reiner, P.B. (1987) Electrophysiological properties of cortically projecting
histamine neurons of rat hypothalamus. Neurosci. Lett., 73, 43±47.
Roozendaal, B. & McGaugh, J.L. (1997) Glucocorticoid receptor agonist and
antagonist administration into the basolateral but not central amygdala
modulates memory storage. Neurobiol. Learn. Mem., 67, 176±179.
Rudy, J. (1996) Scopolamine administered before and after training impairs
both contextual and auditory-cue fear conditioning. Neurobiol. Learn.
Mem., 65, 73±81.
Sacchetti, B., Ambrogi-Lorenzini, C., Baldi, E., Tassoni, G. & Bucherelli, C.
(1999) Auditory thalamus, dorsal hippocampus, basolateral amygdala, and
perirhinal cortex role in the consolidation of conditioned freezing to
context and to acoustic conditioned stimulus in the rat. J. Neurosci., 19,
9570±9578.
Sakai, K., Mansari, M.E., Lin, J., Zhang, J. & Mercier, G.V. (1990) The
posterior hypothalamus in the regulation of wakefulness and paradoxical
sleep. In: Mancia, M. (ed.) The Diencephalon and Sleep. Raven Press, New
York, pp. 171±198.
Schafe, G. & LeDoux, J. (2000) Memory consolidation of auditory Pavlovian
fear conditioning requires protein synthesis and protein kinase A in the
amygdala. J. Neurosci., 20, RC96.
Schafe, G.E., Atkins, C.M., Swank, M.W., Bauer, E.P., Sweatt, J.D. &
Facilitation of memory and ACh release by histamine 527
ã 2002 Federation of European Neuroscience Societies, European Journal of Neuroscience, 16, 521±528
LeDoux, J.E. (2000) Activation of ERK/MAP kinase is required for
memory consolidation of pavlovian fear conditioning. J. Neurosci., 20,
8177±8187.
Schafe, G., Nader, K., Blair, H. & LeDoux, J. (2001) Memory consolidation of
Pavlovian fear conditioning: a cellular and molecular perspective. Trends
Neurosci., 24, 540±546.
Selbach, O., Brown, R. & Haas, H. (1997) Long-term increase of hippocampal
excitability by histamine and cyclic AMP. Neuropharmacology, 36, 1539±
1548.
Toyota, H., Dugovic, C., Koehl, M., Weber, C., Ngo, K., Wu, Y., Lee, D.,
Turek, F., Fung-Leung, W.-P. & Lovenberg, T.W. (2001) Characterization
of mice lacking the histamine H3 receptor. [28th Annual Meeting of the
Society of Neuroscience, San Diego.] Soc. Neurosci. Abstr., 27.
Uhlrich, D., Manning, K. & Xue, J.-T. (2002) Effects of activation of the
histaminergic tuberomammillary nucleus on visual responses of neurons in
the dorsal lateral geniculate nucleus. J. Neurosci., 22, 1098±1107.
Vazdarjanova, A. & McGaugh, J.L. (1999) Basolateral amygdala is involved
in modulating consolidation of memory for classical conditioning.
J. Neurosci., 19, 6615±6622.
Vollinga, R.C., deKoning, J.P., Jansen, F.P., Leurs, R., Menge, W.M.P.B. &
Timmerman, H. (1994) A new potent and selective histamine H3 receptor
agonist, 4-(1H-imidazol-4-yl-methyl) piperidine (immepip). J. Med. Chem.,
37, 332±333.
Watanabe, T., Taguchi, Y., Shiosaka, S., Tanaka, J., Kubota, H., Terano, Y.,
Tohyama, M. & Wada, H. (1984) Distribution of the histaminergic neuron
system in the central nervous system of rats: a ¯uorescent
immunohistochemical analysis with histidine decarboxylase as a marker.
Brain Res., 295, 13±25.
Weeber, E., Atkins, C., Selcher, J., Varga, A., Mirnikjoo, B., Paylor, R.,
Leitges, M. & Sweatt, J. (2000) A role of the b isoform of protein kinase C
in fear conditioning. J. Neurosci., 20, 5906.
Weiler, H.-T., HasenoÈhrl, R., Landeghem, A.V., Landeghem, M.V., Brankack,
J., Huston, J. & Haas, H. (1998) Differential modulation of hippocampal
signal transfer by tuberomammillary nucleaus stimulation in freely moving
rats dependent on behavioral state. Synapse, 28, 294±301.
Whalen, P., Rauch, S., Etcoff, N., McInerney, S., Lee, M. & Jenike, M. (1998)
Masked presentations of emotional facial expressions modulate amygdala
activity without explicit knowledge. J. Neurosci., 18, 411±418.
528 I. Cangioli et al.
ã 2002 Federation of European Neuroscience Societies, European Journal of Neuroscience, 16, 521±528
